Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALYPSO: Deferasirox Granules vs DT in Pediatric Iron Overload
NCT02435212Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of deferasirox in iron overload, sponsored by Novartis. Started Oct 2015; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT02435212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02435212.